(Press-News.org) The world's first international polypill trial has shown that a four-in-one combination pill can halve the predicted risk of heart disease and stroke. The results are published online today in the open access journal PLoS One [1].
The once-a-day polypill contains aspirin and agents to lower blood pressure and cholesterol. These drugs are currently prescribed separately to millions of patients and are known individually to cut the risk of disease, but many experts believe that combining them into a single pill will encourage people to take the medications more reliably.
The trial tested the effectiveness and tolerability of the polypill in 378 people with raised risk of cardiovascular disease, who did not necessarily have high blood pressure or cholesterol, against a placebo. The participants came from the UK, Australia, Brazil, India, New Zealand, The Netherlands, and the USA, with core funding for the central coordination of the trial provided by the Wellcome Trust.
"The results show a halving in heart disease and stroke can be expected for people taking this polypill long-term," said Professor Anthony Rodgers of The George Institute for Global Health, who led the international consortium.
"We know from other trials that long-term there would also be a 25-50% lower death rate from colon cancer, plus reductions in other major cancers, heart failure and renal failure," Professor Rodgers said. "These benefits would take several years to 'kick in', but of course one of the hopes with a polypill is it helps people take medicines long-term."
National trials of similar combination 'polypill' treatments have previously been conducted in India, Iran and Sri Lanka, but this is the first trial to combine data from patients at international centres and the first to look reliably at the incidence of side effects against a placebo.
The authors noted that the benefits, while large, were not as massive as previous researchers have suggested, and the side effects were also not as rare as first thought. In the short-term about 1 in 6 people experienced a side effect. Most were mild but about 1 in 20 overall stopped treatment due to side effects, indicating that treatment is best targeted to those at raised risk of disease.
Professor Simon Thom of Imperial College London, who led the UK arm of the trial, commented: "We now need to conduct larger trials to test whether these medicines are best provided in the form of a polypill, or as separate medicines, and whether this combination strategy improves patient adherence to cardiovascular medication."
This polypill will be available in India soon and then elsewhere within a few years, according to regulatory timelines within each individual country.
Dr Ted Bianco, Director of Technology Transfer at the Wellcome Trust, commented: "Few of us would dissent from the view that prevention is better than cure in most matters medical. It is good news, indeed, to see the evidence base grow for the potential use of a new generation of combination products as a safe and affordable option in the battle against heart attack and stroke."
In the UK, around one in three of all deaths are attributable to cardiovascular disease [2]. Globally, around 80% of all deaths from cardiovascular disease and diabetes occur in low or middle income countries, according to recent estimates [3].
In 2001, the World Health Organisation and the Wellcome Trust convened a meeting of experts to discuss affordable interventions for non-communicable diseases, including the potential of a fixed-dose combination pill to reduce the risk of cardiovascular diseases. From here a programme of research was outlined to assess whether this approach is safe, effective and practical.
INFORMATION:
Additional funding for the trial was provided by the British Heart Foundation, the Health Research Council of New Zealand, the National Heart Foundation of New Zealand, the National Health and Medical Research Council of Australia and the Brazilian Ministry of Health.
END
Results of a study of 1032 patients with early (less than one year), active RA initially assessed response to treatment after 26 weeks with ADA 40mg every other week + MTX versus MTX alone. Results show that 44% of patients treated with the combination therapy achieved the target of sustained low disease activity at week 26, versus 24% of those treated with MTX alone. Patients reaching the target on ADA+MTX were considered responders and then further randomised to continue or withdraw from treatment with ADA 40mg every other week.
Patients who continued treatment maintained ...
The study, involving 257 students, highlights that a higher degree of pain was experienced with the use of gaming devices compared to mobile phones. Pain reported by children using Xbox and Gameboy was statistically higher than pain reported for the iPhone (p=0.036 and p=0.042 respectively). Importantly, the length of time spent on the devices heightened the pain suffered, as the data demonstrated that length of time was independently associated with the pain reported, with the odds of reporting pain increasing by two (95* CI [1.50, 2.89, p END ...
Most adverse events were mild and no new safety signals were reported, according to study authors.
Results of the 12 month multinational study, conducted with 792 patients also show that 36.6% and 16.2% of patients achieved ACR50 and ACR70 responses respectively in the 10mg BID group, a significant improvement in symptoms compared to placebo, where 31.2%, 12.7% and 3.2% of patients achieved ACR 20, 50 and 70 respectively. Significant improvements in the Disease Activity Score physician index (DAS28***) were also observed in the treatment groups compared to placebo, along ...
An international team of UK and US astronomers have spotted the most distant explosion, and possibly the most distant object, ever seen in the Universe.
University of Warwick astronomer Dr Andrew Levan was one of the first members of that team to spot the exploding star, known as a Gamma-ray Burst (GRB), which was briefly as bright as several thousand galaxies (more than a million million times the brightness of the sun). This very bright explosion allowed it to be detected at an extreme estimated distance of 13.14 billion light years - putting it 96% of the way to ...
Northridge dentist, Dr. Farshid Ariz, DMD, and Dr. Shahdad Arami, DDS, are popular with local residents for many reasons. The technologies that are provided to diagnose and treat dental problems constantly evolve, but these dentists make new investments in technology and stay current with the required education to provide safe and precision dental care. The i-CAT and E4D technologies are now used at Northridge Dental Group to provide patients with safer and more comfortable treatments.
Early detection is a key component in diagnosing severe gum diseases like periodontal ...
STANFORD, Calif. — A widely used combination of two common medications may cause unexpected increases in blood glucose levels, according to a study conducted at the Stanford University School of Medicine, Vanderbilt University and Harvard Medical School. Researchers were surprised at the finding because neither of the two drugs — one, an antidepressant marketed as Paxil, and the other, a cholesterol-lowering medication called Pravachol — has a similar effect alone.
The increase is more pronounced in people who are diabetic, and in whom the control of blood sugar levels ...
Japan's earthquake, tsunami and nuclear power plant damage have done more than reduce shipments of popular automobiles and car parts to the United States. Damage from the March disaster at Japanese chemical plants that produce raw materials for the electronics components, although modest in itself, has had some of the most severe impacts in history on the global electronics industry. That's the message from one story in a package of status reports on the disaster in the current edition of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
In the articles, C&EN ...
"Sweet wheat" has the potential for joining that summertime delight among vegetables — sweet corn — as a tasty and healthful part of the diet, the scientific team that developed this mutant form of wheat concludes in a new study. The report appears in the ACS' Journal of Agricultural and Food Chemistry.
Just as sweet corn arose as a mutation in field corn — being discovered and grown by Native American tribes with the Iroquois introducing European settlers to it in 1779 — sweet wheat (SW) originated from mutations in field wheat. Toshiki Nakamura, Tomoya Shimbata and ...
The formation of abnormal strands of protein called amyloid fibrils — associated with two dozen diseases ranging from Alzheimer's to type-2 diabetes — may not be permanent and irreversible as previously thought, scientists are reporting in the Journal of the American Chemical Society. Rather, protein molecules are constantly attaching and detaching from the fibrils, in a recycling process that could be manipulated to yield new treatments for Alzheimer's and other diseases.
In a study that focused on the fibrils associated with Alzheimer's disease (AD), Natàlia Carulla ...
Temptations to exceed the speed limit are always plentiful, but only reckless drivers give in to such impulses. Likewise, numerous growth factors always abound in our bodies, but only cancerous cells are quickly "tempted" by these chemicals to divide again and again. Healthy cells, in contrast, divide only after being exposed to growth factors for eight continuous hours. What happens during these eight hours in a healthy cell that resists the call to divide? And even more important, what fails to work properly in the cancerous cell during these same hours? Why do cancerous ...
